Document ID: chunk:federal_register_of_legislation:F2016L01683:reg:7
Version: federal_register_of_legislation:F2016L01683
Segment Type: reg
Provision Reference: reg 7
Character Range: 1640–3212

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about fibromuscular dysplasia and death from fibromuscular dysplasia.
Meaning of fibromuscular dysplasia
(2)          For the purposes of this Statement of Principles, fibromuscular dysplasia means a nonatherosclerotic, noninflammatory segmental stenosing disease of the muscle layer of arterial walls, with or without focal aneurysmal outpouchings of the affected artery.  The disease commonly involves medium-sized arteries and is most often found in the renal artery and the internal carotid artery.
(3)          While fibromuscular dysplasia attracts ICD‑10‑AM code I77.3, in applying this Statement of Principles the meaning of fibromuscular dysplasia is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5.
Death from fibromuscular dysplasia
(5)          For the purposes of this Statement of Principles, fibromuscular dysplasia, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's fibromuscular dysplasia.
Note: terminal event is defined in the Schedule 1 – Dictionary.